Seth Klarman - Baupost Group
Holding/activity history for Atara Biotherapeutics Inc (ATRA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q4 | 0 | 0.00 | Sell 100.00% | 0.28 | SEC | ||
| 2023 Q3 | 9,773,616 | 0.28 | $1.48 | $14,465,000 | SEC | ||
| 2023 Q2 | 9,773,616 | 0.29 | Add 7.12% | 0.02 | $1.61 | $15,736,000 | SEC |
| 2023 Q1 | 9,123,616 | 0.47 | Add 12.31% | 0.05 | $2.90 | $26,458,000 | SEC |
| 2022 Q4 | 8,123,616 | 0.45 | $3.28 | $26,645,000 | SEC | ||
| 2022 Q3 | 8,123,616 | 0.55 | $3.78 | $30,707,000 | SEC | ||
| 2022 Q2 | 8,123,616 | 0.98 | $7.79 | $63,283,000 | SEC | ||
| 2022 Q1 | 8,123,616 | 0.84 | Reduce 4.17% | 0.06 | $9.29 | $75,468,000 | SEC |
| 2021 Q4 | 8,477,488 | 1.36 | $15.76 | $133,605,000 | SEC | ||
| 2021 Q3 | 8,477,488 | 1.41 | $17.90 | $151,747,000 | SEC | ||
| 2021 Q2 | 8,477,488 | 1.08 | $15.55 | $131,825,000 | SEC | ||
| 2021 Q1 | 8,477,488 | 0.98 | Reduce 6.93% | 0.12 | $14.36 | $121,737,000 | SEC |
| 2020 Q4 | 9,108,988 | 1.68 | Reduce 8.19% | 0.11 | $19.63 | $178,809,000 | SEC |
| 2020 Q3 | 9,922,030 | 1.39 | $12.96 | $128,590,000 | SEC | ||
| 2020 Q2 | 9,922,030 | 1.81 | Add 19.41% | 0.29 | $14.57 | $144,564,000 | SEC |
| 2020 Q1 | 8,308,900 | 1.05 | $8.51 | $70,709,000 | SEC | ||
| 2019 Q4 | 8,308,900 | 1.59 | $16.47 | $136,848,000 | SEC | ||
| 2019 Q3 | 8,308,900 | 1.46 | Add 18.70% | 0.23 | $14.12 | $117,322,000 | SEC |
| 2019 Q2 | 7,000,000 | 1.38 | Add 9.71% | 0.12 | $20.11 | $140,770,000 | SEC |
| 2019 Q1 | 6,380,519 | 2.28 | Add 2.01% | 0.05 | $39.75 | $253,626,000 | SEC |
| 2018 Q4 | 6,254,632 | 1.97 | $34.74 | $217,286,000 | SEC | ||
| 2018 Q3 | 6,254,632 | 2.03 | $41.35 | $258,629,000 | SEC | ||
| 2018 Q2 | 6,254,632 | 2.07 | $36.75 | $229,858,000 | SEC | ||
| 2018 Q1 | 6,254,632 | 2.38 | Add 16.70% | 0.34 | $39.00 | $243,931,000 | SEC |
| 2017 Q4 | 5,359,632 | 0.97 | $18.10 | $97,009,000 | SEC | ||
| 2017 Q3 | 5,359,632 | 1.13 | $16.55 | $88,702,000 | SEC | ||
| 2017 Q2 | 5,359,632 | 0.90 | $14.00 | $75,035,000 | SEC | ||
| 2017 Q1 | 5,359,632 | 1.33 | $20.55 | $110,140,000 | SEC | ||
| 2016 Q4 | 5,359,632 | 1.02 | $14.20 | $76,107,000 | SEC | ||
| 2016 Q3 | 5,359,632 | 1.69 | $21.39 | $114,643,000 | SEC | ||
| 2016 Q2 | 5,359,632 | 1.69 | $22.51 | $120,645,000 | SEC | ||
| 2016 Q1 | 5,359,632 | 1.51 | $19.03 | $101,994,000 | SEC | ||
| 2015 Q4 | 5,359,632 | 2.79 | $26.41 | $141,548,000 | SEC | ||
| 2015 Q3 | 5,359,632 | 3.01 | Add 11.44% | 0.31 | $31.44 | $168,507,000 | SEC |
| 2015 Q2 | 4,809,632 | 4.81 | Add 0.97% | 0.05 | $52.76 | $253,756,000 | SEC |
| 2015 Q1 | 4,763,265 | 3.55 | Add 90.84% | 1.69 | $40.48 | $192,802,000 | SEC |
| 2014 Q4 | 2,495,913 | 1.27 | Buy | 1.27 | $23.69 | $59,137,000 | SEC |